Colony NorthStar, Inc. (NYSE: CLNS) Investor Securities Class Action Lawsuit 04/06/2018

If you purchased a significant amount of shares of Colony NorthStar, Inc. (NYSE: CLNS) between February 28, 2017 and March 1, 2018, and / or if you purchased any NYSE: CLNS shares prior to February 2017 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: June 5, 2018. NYSE: CLNS investors should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Company Name(s): 
Colony NorthStar
Case Name: 
Colony NorthStar Shareholder Class Action Lawsuit 04/06/2018
Case Status: 
Lawsuit Filed
Affected Securities
NYSE: CLNS
Lawsuit Overview
Type of Lawsuit: 
Shareholder Class Action
Date Filed: 
04/06/2018
Class Period Begin: 
02/28/2017
Class Period End: 
03/01/2018
Court of Filing: 
U.S. District Court for the Central District of California
Deadline To File for Lead: 
06/05/2018
Summary: 

An investor in shares of Colony NorthStar, Inc. (NYSE: CLNS) filed a lawsuit in the U.S. District Court for the Central District of California over alleged violations of Federal Securities Laws by Colony NorthStar, Inc. in connection with certain allegedly false and misleading statements made between February 28, 2017 and March 1, 2018.

Los Angeles, CA based Colony NorthStar is a diversified equity REIT with an embedded institutional and retail investment management business.

On January 10, 2017, NorthStar Asset Management Group Inc., Colony Capital, Inc. and NorthStar Realty Finance Corp. closed their merger announced in 2016 with $56 billion of assets under management.

On February 28, 2017, Colony NorthStar, Inc. reported its fourth quarter 2016 financial results. Among other things, Colony NorthStar, Inc. updated its 2017 guidance.

Shares of Colony NorthStar, Inc. (NYSE: CLNS) reached $14.35 per share in July 2017.

On March 1, 2018, Colony NorthStar, Inc. announced its fourth quarter and full year 2017 financial results. Colony NorthStar, Inc. reported that its annual Total Revenue rose from $208.47 million in 2016 to $720.34 million in 2017 and that its Net Income of $24.65 million in 2016 turned into a Net Loss of $294.58 million in 2017.

Shares of Colony NorthStar, Inc. (NYSE: CLNS) declined from $9.00 per share in early February 2018 to as low as $5.28 per share on March 1, 2018.

According to the complaint the plaintiff alleges on behalf of purchasers of Colony NorthStar, Inc. (NYSE: CLNS) common shares between February 28, 2017 and March 1, 2018, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 28, 2017 and March 1, 2018, the defendants made false and/or misleading statements and/or failed to disclose that Colony NorthStar’s Healthcare and Investment Management segments were performing worse than reported and that as a result, Colony NorthStar’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.